Correlation Between Basilea Pharmaceutica and Banque Cantonale

Can any of the company-specific risk be diversified away by investing in both Basilea Pharmaceutica and Banque Cantonale at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Basilea Pharmaceutica and Banque Cantonale into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Basilea Pharmaceutica AG and Banque Cantonale, you can compare the effects of market volatilities on Basilea Pharmaceutica and Banque Cantonale and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Basilea Pharmaceutica with a short position of Banque Cantonale. Check out your portfolio center. Please also check ongoing floating volatility patterns of Basilea Pharmaceutica and Banque Cantonale.

Diversification Opportunities for Basilea Pharmaceutica and Banque Cantonale

0.26

Correlation Coefficient

Basilea Pharmaceutica  Banque Cantonale

Modest diversification

The 3 months correlation between Basilea and Banque is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Basilea Pharmaceutica AG and Banque Cantonale in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Banque Cantonale and Basilea Pharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Basilea Pharmaceutica AG are associated (or correlated) with Banque Cantonale. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Banque Cantonale has no effect on the direction of Basilea Pharmaceutica i.e., Basilea Pharmaceutica and Banque Cantonale go up and down completely randomly.

Pair Corralation between Basilea Pharmaceutica and Banque Cantonale

Assuming the 90 days trading horizon Basilea Pharmaceutica AG is expected to under-perform the Banque Cantonale. But the stock apears to be less risky and, when comparing its historical volatility, Basilea Pharmaceutica AG is 1.09 times less risky than Banque Cantonale. The stock trades about -0.12 of its potential returns per unit of risk. The Banque Cantonale is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  8,690  in Banque Cantonale on October 24, 2024 and sell it today you would earn a total of  250.00  from holding Banque Cantonale or generate 2.88% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.77%
Values	Daily Returns

Basilea Pharmaceutica AG  vs.  Banque Cantonale

Basilea Pharmaceutica

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Basilea Pharmaceutica AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Banque Cantonale

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Banque Cantonale are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Banque Cantonale is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Basilea Pharmaceutica and Banque Cantonale

The main advantage of trading using opposite Basilea Pharmaceutica and Banque Cantonale positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Basilea Pharmaceutica position performs unexpectedly, Banque Cantonale can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Banque Cantonale will offset losses from the drop in Banque Cantonale's long position.

The idea behind Basilea Pharmaceutica AG and Banque Cantonale pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.